October 21, 2014 5:52 PM ET


Company Overview of Resolvyx Pharmaceuticals, Inc.

Company Overview

Resolvyx Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes resolvin therapeutics to treat a range of inflammatory diseases. It provides RX-10001, a small molecule lipid mediator that acts to protect healthy tissue during an inflammatory response to an environmental insult and to resolve inflammation once the environmental insult has passed; RX-10045, a synthetic resolvin analog formulated for topical application to treat eye disease; and RX-20001, a small molecule lipid mediator derived from the omega-3 fatty acid DHA that treats eye disease and lung inflammation. Resolvyx Pharmaceuticals, Inc. was formerly known as Chalone Pharmaceuticals, Inc. and ...

25 First Street

Cambridge, MA 20141

United States

Founded in 2001





Key Executives for Resolvyx Pharmaceuticals, Inc.

Chief Executive Officer
Executive Chairman
Vice President of Chemistry
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Signase, Inc United States
Tonbo Biotechnologies Corporation United States
Biothera, Inc. United States
Kinetic Biosystems United States
Nutech Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Resolvyx Pharmaceuticals, Inc., please visit www.resolvyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.